Intravenous immunoglobulin (IVIG) has been utilized in patients with recurrent and refractory Clostridium difficile colitis. It is increasingly being used in patients with initial clinical presentation of severe colitis. Herein, we report a case of severe C. Difficile colitis successfully treated with IVIG with a review of the medical literature to identify the optimal timing and clinical characteristics for this treatment strategy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049046 | PMC |
| http://dx.doi.org/10.4103/0974-777X.132053 | DOI Listing |
Publication Analysis
Top Keywords
difficile colitis
12
intravenous immunoglobulin
8
clostridium difficile
8
immunoglobulin treatment
4
treatment severe
4
severe clostridium
4
colitis
4
colitis intravenous
4
immunoglobulin ivig
4
ivig utilized
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!